• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20001 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (new therapeutic indication, Waldenstroem macroglobulinaemia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (new therapeutic indication, chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (CLL) - Benefit assessment according to §35a Social Code Book V]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (chronic lymphocytic leukaemia): benefit assessment according to §35a Social Code Book V]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (chronic lymphocytic leukaemia): Addendum to Commission A16-39]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib - Benefit assessment according to §35a Social Code Book V]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib - addendum to commission A16-04]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibalizumab (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2011     Committee for New Health Technology Assessment (CNHTA) [I-125 permanent implant for prostate cancer]
2008     Finnish Office for Health Care Technology Assessment (Finohta) [Hysteroscopic sterilisation using a metal micro-insert]
2021     Norwegian Institute of Public Health (NIPH) [Hysterectomy for heavy menstrual bleeding: rapid health technology assessment]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Hypothermia therapy for treatment of neonatal hypoxic-ischemic encephalopathy]
2020     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Hypoglossal nerve stimulation systems for treatment of obstructive sleep apnea]
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hyperthermic intraperitoneal chemotherapy]
2013     Andalusian Health Technology Assessment Area (AETSA) [Hyperthermic intraperitoneal chemotherapy. Efficacy and safety in the treatment of ovarian cancer peritoneal carcino matosis]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hyperthermia]
2020     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Hyperbaric oxygenotherapy for fybromialga, peripheral vascular disease, neurological disease and other indications]
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hyperbaric oxygen treatment of injuries after radiotherapy for head and neck cancer - a health technology assessment]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy in pseudoarthrosis]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy in lateral sinus thrombosis]
2020     Norwegian Institute of Public Health (NIPH) [Hyperbaric oxygen therapy for radiation-induced cystitis]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy for diabetic foot syndrome]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy for chronic ulcers]
2009     Committee for New Health Technology Assessment (CNHTA) [Hyoid myotomy suspension]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Hydrotherapy in skeletal muscle disorders]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hydrocortisone (adrenal insufficiency) - Benefit assessment according to §35a Social Code Book V]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hybrid operating room]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyaluronic acid dermal fillers in skin repair procedures]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Human papilloma virus (HPV) vaccine in patients with HPV lesions or infection]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Human assisted reproductive techniques: Description of the available therapeutic options]
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [HTA, health services research, and clinical practice. Report from a symposium in evidence based health care]
2008     Norwegian Knowledge Centre for the Health Services (NOKC) [HPV RNA test for cervical cancer]
2008     Committee for New Health Technology Assessment (CNHTA) [HPV genotype(PCR-RFMP)]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [How to improve the management of depression? A qualitative approach]
2009     The Swedish Council on Health Technology Assessment (SBU) [How can drug consumption among the elderly be improved?]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hospice without walls]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Hormones for therapy of climacteric afflictions]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Hormone receptor testing in breast cancer]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Home-based rehabilitation of patients suffering from stroke]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients with moderate-severe malnutrition undergoing active treatment]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients who require modification of the usual ordinary diet due to mucositis]
2009     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Home visits to patients with severe COPD - a health technology assessment]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Home health care of patients with terminal illnesses in the Basque Autonomous Community]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home enteral nutrition in older patients with severe protein-energy malnutrition after hip fracture]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Home diagnosis of obstructive sleep apnea in children]
2010     The Swedish Council on Health Technology Assessment (SBU) [Home blood pressure monitoring]
2023     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Home abortion]
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Holmium laser enucleation of benign prostatic hyperplasia]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Holmium laser enucleation in benign prostatic hyperplasia]
2008     Committee for New Health Technology Assessment (CNHTA) [HLA-B51, genotyping[allele-specific PCR]]
2008     Committee for New Health Technology Assessment (CNHTA) [HLA-B51 nested PCR]
2010     Committee for New Health Technology Assessment (CNHTA) [HLA antibody identification, single antigen class i, class ii (luminex)]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [HIV screening in the general population]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [HIV infection detection quick test]
2008     Committee for New Health Technology Assessment (CNHTA) [HIV antibody test (including oral fluid)]
1999     Basque Office for Health Technology Assessment (OSTEBA) [Hip replacement: indications of appropriate use]
2000     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Hip replacement with osteoarthritis]
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hip protectors in long-term care]
2014     Haute Autorite de sante (HAS) [Hip implants]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hip arthroscopy for painful hip treatment]
2009     Committee for New Health Technology Assessment (CNHTA) [HINT (Hearing in Noise Test)]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [High-intensity focused ultrasound for prostate cancer]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [High-flow therapy for self-use in advanced COPD or chronic type 1 respiratory failure]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [High-dose rate brachytherapy in the treatment of mobile tongue cancer]
2012     Andalusian Health Technology Assessment Area (AETSA) [High-dose chemotherapy in the salvage treatment of metastatic germ cell tumours]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [High throughput and comprehensive resequencing of cardiomyopathy genes by CHIP based DNA-sequencing technology (CardioCHIP)]
2008     Committee for New Health Technology Assessment (CNHTA) [High intensity focused ultrasound]
2021     Andalusian Health Technology Assessment Area (AETSA) [High intensity focused ultrasound (HIFU) in organ-confined prostate tumors]
2010     Haute Autorite de sante (HAS) [High intensity focalized ultrasound for the treatment of localized prostate cancer]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [High frequency chest compression vest for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [High frequency chest compression for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [High frequency ablation of the endometrium using a mesh electrode in patients with menorrhagia]
2012     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [High dose brachytherapy for head and neck carcinomas]
2009     Committee for New Health Technology Assessment (CNHTA) [High density EEG dipole source localization]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [High altitude simulation test for patients with lung disease]
2018     Basque Office for Health Technology Assessment (OSTEBA) [HIFU —High intensity focused ultrasound— in essential tremor]
2012     Andalusian Health Technology Assessment Area (AETSA) [Heterochromatic flicker photometry for the detection of the risk of age-related macular degeneration]
2010     Norwegian Knowledge Centre for the Health Services (NOKC) [Heroin maintenance for persons with chronic heroin dependence]
2007     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hereditary nonpolyposis colorectal cancer in Denmark - a health technology assessment]
2008     Committee for New Health Technology Assessment (CNHTA) [Hereditary hemorrhagic telangiectasia type 2 (HHT-2), ACVRL2 gene point mutation analysis]
2008     Committee for New Health Technology Assessment (CNHTA) [Hereditary hemorrhagic telangiectasia type 2 (HHT-1), ENG gene point mutation analysis]
2008     Andalusian Health Technology Assessment Area (AETSA) [HER2 in selecting candidates to treatment with Trastuzumab. Determining HER2 status in breast cancer women]
2008     Andalusian Health Technology Assessment Area (AETSA) [HER2 in selecting candidates to treatment with Trastuzumab. Determining HER2 status in breast cancer women.]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hepatitis C virus screening in hospitals]
2003     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hepatitis B vaccination in Denmark]
2009     Committee for New Health Technology Assessment (CNHTA) [Heparin-Platelet Factor 4(PF4) antibody test]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Heparin-bonded vascular prostheses for the treatment of peripheral artery disease]
2013     Basque Office for Health Technology Assessment (OSTEBA) [Hemoperfusion with polymyxin-B for the treatment of sepsis of abdominal origin by gram negative microorganisms]
2010     Committee for New Health Technology Assessment (CNHTA) [Hemoperfusion with Polymyxin B immobilized fiber]
2013     Andalusian Health Technology Assessment Area (AETSA) [Hemodynamic monitoring techniques in the intensive care units]
2002     Basque Office for Health Technology Assessment (OSTEBA) [Hemodilution and perioperative blood recovery]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Helping Hands - comparing short-term and sustained effects of strategies to improve nurses' adherence with hand hygiene prescriptions]
2009     Andalusian Health Technology Assessment Area (AETSA) [Helical tomotherapy. Current uses and utility]
1994     Basque Office for Health Technology Assessment (OSTEBA) [Healthy/asymptomatic patient preoperative evaluation]
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health Technology Assessment. Why? What? When? How?]
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment report on metal on metal hip resurfacing versus total hip replacement]
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment perspectives on prescription writing]
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Health Technology Assessment on diagnostic testing: Cardiac MRI and MRSA genetic testing (Real-time polymerase chain reaction)]